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Development of a Microsphere-based Immunoassay for the Detection of IgM Antibodies  
 
to West Nile Virus and St. Louis Encephalitis Virus in Sentinel Chicken Sera 
 
Logan C. Haller 
ABSTRACT 
 
 
West Nile virus (WNV) and St. Louis Encephalitis (SLEV) are arthropod-borne 
viruses belonging to the genus Flavivirus and are classified as significant human 
pathogens of global epidemiological importance.  Since its introduction into the United 
States in 1999, WNV has spread throughout most of the country and has caused major 
epidemics of neuroinvasive disease (Hayes and Gubler, 2005).  SLEV is endemic to the 
United States and is maintained in an enzootic transmission cycle in Florida.     
  The Florida Sentinel Chicken Arboviral Surveillance Network was established in 
1978 following a widespread rural epidemic of SLEV in central Florida to monitor the 
activity of arboviruses (Day and Stark, 1996).  This program ultimately impacts vector 
control strategies and may warrant medical alerts to warn the population.   
Current serological detection methods for sentinel chickens include 
hemagglutination inhibition antibody test (HAI), IgM antibody capture enzyme-linked  
immunosorbent assay (MAC-ELISA), and Plaque Reduction Neutralization Test (PRNT). 
These serological assays may take over three weeks to generate a final result.  A more 
rapid and equally sensitive test to replace these current serological methods would be of 
benefit.     
ix  
Microsphere-based immunoassays (MIAs) are a more rapid serological option for 
laboratory diagnosis of many diseases (Kellar et al, 2001).  The objective of this study 
was to develop and validate a protocol for a MIA to detect antibodies to WNV and SLEV 
in sentinel chicken sera.  A total of 385 sentinel chicken sera from 2005 were assayed 
using the MIA for WNV and 424 sera from multiple years were assayed for SLEV.  The 
capability of the MIA to multiplex allowed for simultaneous detection of antibodies to 
WNV and SLEV in sentinel chicken sera. 
The MIA was found to be more sensitive and specific than both the HAI and 
MAC-ELISA for the detection of antibodies to WNV, and just as sensitive and specific as 
the MAC-ELISA for the detection of antibodies to SLEV in sentinel chicken sera.  These 
results indicate that there is a potential of the MIA to decrease turn-around time and 
allow for earlier detection and improvement to the current surveillance system.   
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Introduction 
 
Arboviruses 
Arboviruses (arthropod-borne viruses) are viruses maintained in nature through 
cycles involving hematophagous (blood sucking) arthropod vectors and vertebrate hosts 
(Beaty, et al, 1989).   There are more than 534 viruses registered in the International 
Catalogue of Arboviruses; 134 (25%) have been documented as causing illness in 
humans (Karabatsos, 1985).  The medically important arboviruses belong to three virus 
families:  the Bunyaviridae, Flaviviridae, and Togaviridae (Gubler & Roehrig, 1998).       
Arboviral activity can be classified as enzootic and involves sporadic, 
intermittent, or epidemic cases resulting in significant outbreaks in humans, horses, and 
birds.  In the United States, birds and rodents may serve as amplifying hosts and 
mosquitoes play an important role in transmission.  Infected mosquitoes can spread the 
virus from the enzootic amplifying host to horses, other animals and people.  For most 
arboviruses, humans and domestic animals are considered dead-end or incidental hosts 
because they do not develop high enough levels of viremia to infect the arthropod vector 
and continue the transmission cycle.  Dengue virus is one exception and has adapted 
completely to humans and is maintained in a mosquito-human-mosquito transmission 
cycle in urban centers of the tropics and sub-tropics (Gubler, 2002).   
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Arboviruses are distributed worldwide, but are commonly found in tropical areas  
where the climate can support year-round transmission by cold-blooded arthropods  
(Gubler, 2002).  The presence of these arboviruses in a particular area depends on the 
availability of specific species of mosquitoes and changing epidemiological trends. 
Population growth, uncontrolled urbanization, new irrigation systems, and deforestation 
in tropical developing countries have especially contributed to the emergence and 
resurgence of arboviral diseases in several regions of the world (Gubler, 2001).  This is a 
major public health concern, as these viruses can cause outbreaks of disease in areas 
where virus transmission has not occurred, or was previously controlled.  For example, in 
1999, West Nile Virus (WNV) was introduced into North America.  Unlike WNV strains 
found in the eastern hemisphere, the North American strain is highly pathogenic, virulent, 
and has caused severe neurological disease epidemics and epizootics in humans, birds, 
and horses (Gubler, 2002).  This highly pathogenic WNV strain evolved from a less 
pathogenic strain found in the Middle East, Israel, India, France, and South America 
(Lanciotti et al, 1999).   
Flaviviruses 
Many flaviviruses (a genus of the family Flaviviridae) are significant human 
pathogens, including the four serotypes of dengue virus, yellow fever virus, Japanese 
encephalitis virus, tick-borne encephalitis virus, St. Louis encephalitis virus, and West 
Nile virus (Burke & Monath, 2001).   These viruses are transmitted to humans from the 
bite of an arthropod vector.  WNV and SLEV belong to the Japanese Encephalitis 
Antigenic Serocomplex.     
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 Flaviviruses are spherical, lipid-enveloped RNA viruses approximately 50 nm in 
diameter with a 30 nm core.  The genome consists of single-stranded positive sense RNA 
of approximately 11,000 nucleotides.  This RNA encodes structural capsid (C) protein,  
envelope (E) protein, membrane/matrix (M) protein and seven non structural (NS)  
proteins (Mackenzie, Gubler, and Petersen, 2004).  E protein, NS1, and NS3 are the most 
immunogenic proteins during a flavivirus infection (Hill et al., 1993).  Envelope proteins 
are the major surface proteins and considered to be an important factor in receptor 
binding and membrane fusion with host cells.  The E protein stimulates neutralizing 
antibody response and changes in this protein affect WNV virulence (Hayes & Gubler, 
2005).  Membrane/matrix proteins are responsible for the maturation of immature viral 
particles into infectious forms and C proteins help build nucleocapsids (Knipe and 
Hawley, 2001).   
 The binding of E protein to a host cell receptor allows the viron to enter the cell 
via receptor mediated endocytosis.  Once inside the cell, viral nucleopcapsids are 
dissembled.  Transcription of the virons into messenger RNA (mRNA) is followed by 
translation into various proteins (Chambers et al, 1990).  A large polyprotein results from 
the translation of mRNA and is later divided by proteases into ten or more separate 
products.  The RNA genome is replicated in the cytoplasm, viral particles assemble and 
mature inside the lumen of endoplasmic reticulum and the virion is released from the host 
cell (Knipe and Hawley, 2001). 
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West Nile Virus (WNV) 
Discovery  
West Nile virus was first isolated from the blood of a febrile patient in the West 
Nile region of Uganda in 1937 (Smithburn et al, 1940).  Thirteen years later, additional 
isolates were obtained from the blood of three apparently healthy children (Melnick et al, 
1951).  Researchers were able to show that WNV was antigenically related to two other 
arboviruses known to cause encephatilitis, St. Louis encephalitis virus (SLEV) and 
Japanese encephalitis (JE) virus (Smithburn, 1942). 
Epidemiology 
In Africa and Asia, WNV is endemic with outbreaks occurring every few years 
during the late summer and fall months.  Significant epidemics were reported in Israel in 
the 1950’s, the Rhone delta region of France in 1962, South Africa in 1974, and Romania 
in 1996 (Hayes 1989).    
West Nile virus was first detected in North America in 1999 during an outbreak of 
encephalitis in New York City (Hayes and Gubler, 2005).  At first mistaken for St. Louis 
encephalitis virus (SLEV), researchers identified WNV by its high mortality in birds.  
The virus appeared to be a highly virulent strain of WNV introduced possibly from Israel 
(Lanciotti et al, 1999).  Since its 1999 appearance in New York City, WNV has spread 
across North America and into Canada, Latin America, and the Caribbean.  The largest 
epidemics of neuroinvasive WNV disease ever reported occurred in the United States in 
2002 and 2003 (Hayes and Gubler, 2005).  West Nile virus has emerged as a major public 
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health threat and rapidly impacted humans, horses, and birds throughout the western 
hemisphere.   
Transmission 
The rapid spread of WNV may be due in part to its transmission cycle.  WNV is 
maintained in an enzootic transmission cycle between birds and Culex mosquitoes, with 
humans and horses as incidental hosts (Blackmore et al, 2003).  Infectious mosquitoes 
carry virus particles in their salivary glands and infect susceptible birds during blood 
meal-feeding.  In the temperate zone, transmission occurs during the warmer months with 
peak activity from July-October (O’Leary et al, 2004).  The main competent bird 
reservoirs are corvids (crows, jays and magpies), house sparrows, house finches, and 
grackles (Komar, 2003).  Field studies conducted in different geographical areas 
corroborated the importance of birds in the transmission cycle of WNV based on the 
presence of high antibody rates in birds (Hayes, 2001).  It is thought that the spread of 
WNV throughout the United States is due to the migration patterns of these bird 
reservoirs (Rappole and Hubalek, 2003).  Alligators may also serve as a reservoir for 
WNV in the southeastern United States (Klenk et al, 2004).  Since 2002, it has been 
noted that human-to-human transmission of WNV can also occur through blood 
transfusion, organ transplantations, trans-placentally, and possibly through breastfeeding 
(Pearler et al, 2003).   
Clinical Features 
WNV infection is characterized by an acute onset of fever, headache, malaise, 
fatigue, weakness, muscle pain, and difficulty concentrating.  However, approximately 
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80% of WNV infections are asymptomatic, 20% result in self limiting West Nile virus 
fever (WNF), and <1% results in neuroinvasive disease (Hayes, 1989).  Symptomatic 
illness develops 2-14 days after virus transmission in humans (Mackenzie, Gubler, and 
Petersen, 2004).   
Immune Response 
WNV replicates in dendritic cells at the site of infection, spreads to regional 
lymph nodes, and then progresses to the blood stream.  In one study, Wang et al. (2004) 
showed evidence that binding of viral RNA to toll-like receptor-3 induces permeability of 
the blood-brain barrier, which allows viral penetration of the central nervous system in 
mice.  This indicates that WNV can directly invade neurons, deep nuclei of the brain, and 
interior horn cells in the spinal cord.  It has also been noted that CD8 T cells are involved 
in both the immunopathology of and recovery from WNV infection (Wang, et al., 2003).  
These studies have aided in the identification of the clinical symptoms that may be 
present with a WNV infection. 
  An array of antibody types and subclasses is produced by the normal host 
humoral response to viral infection.  IgM antibody is produced early in the immune 
response and may indicate an acute recent infection (Martin et al, 2000).   
St. Louis Encephalitis Virus (SLEV) 
Prior to the outbreak of WNV in New York City, St. Louis encephalitis virus 
(SLEV) was the most important agent of epidemic viral encephalitis in North America 
and the only mosquito-borne human pathogen in the family Flaviviridae found in this 
continent (Hunt et al, 2002; Tsai & Monath, 1987).  SLEV was first identified as the 
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cause of human disease in North America after a large urban epidemic in St. Louis, 
Missouri, during the summer of 1933 (Day 2001).  Over the past 70 years, SLEV has 
been responsible for important epidemics throughout the United States (Monath & Heinz, 
1996).  The last major outbreak of SLEV in the United States occurred in 1974 to 1977, 
when more than 2500 human cases were reported (Johnson et al, 2005).  The severity of 
SLEV disease in humans is dependent on age. During epidemics, incidence of disease in 
people older than 60 is generally 5-40 times greater than in those less than 10 years old.  
Frequency of encephalitis (the most severe symptom associated with SLEV) is also age-
dependent, increasing from 56%, for those age 20 or younger, to 87% for those over 60. 
In addition, mortality is 7-24% among those over 50, and less than 5% for those under 50 
(Shroyer, 1990). The first indication that SLEV was a threat to the human population of 
Florida came in 1952 when the virus was isolated from a 30-year-old Miami man 
(Sanders et al, 1953).  Major SLEV epidemics occurred in Florida in 1959, 1961, 1962, 
1977 and 1990 (Shroyer, 1990).  However, enzootic SLEV transmission is silent in nature 
with no reports of avian mortality, unlike the high rates of avian mortality associated with 
WNV in the western hemisphere (Lanciotti and Kerst et al, 2001).   
SLEV is maintained in an enzootic transmission cycle between birds and Culex 
mosquitoes.  In tropical America, SLEV has also been isolated from many non-Culex 
mosquito species (Charrel et al, 1999).  The case fatality ratio for human disease is 
variable depending upon different geographical locations and conditions (Monath and 
Heinz, 1996).  WNV and SLEV infections often present with similar clinical profiles, 
sudden onset of fever, headache, and myalgia, and have similar prevention measures 
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(Johnson et al, 2005).  These closely related viruses share many antigenic, genetic, and 
ecologic characteristics (Chambers et al, 1990). 
Treatment and Prevention    
Currently, there are no approved human vaccines for WNV or SLEV and clinical 
options for treatment of infection are limited.  Arroyo et al. (2004) investigated the 
immunogenicity, safety, and efficacy of a ChimeriVax-West Nile Virus live attenuated 
vaccine.  Pre-clinical studies are in progress on this vaccine and further investigation is 
required before its approval for widespread vaccination of humans (Arroyo et al, 2004).  
Although there are no current WNV vaccines approved for use in humans, there are two 
commercially available recombinant WNV DNA vaccines for horses (Davis et al., 2001).  
The main mode of prevention is to control the vector population (mosquitoes) through 
integrated vector control management programs and personal protection behaviors.  A 
surveillance network of federal, state, and local health departments monitors arboviral 
activity in wildlife hosts, vectors, and humans (Gubler, 2002).   
Surveillance   
Surveillance systems serve as an early warning for the transmission of disease and 
aim to limit or prevent human cases.  Arbovirus surveillance programs have used 
antibody development in sentinel birds to monitor transmission cycles for decades (CDC, 
1993).  A few states use sentinel chicken flocks scattered throughout regions at greatest 
risk for WNV, SLEV, and other arboviruses (where Florida is a primary monitoring 
region).  WNV and SLEV are maintained in nature by birds and therefore infections in 
avian hosts should occur more frequently (and earlier) than disease in people or horses.  
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Transmission of WNV and SLEV to sentinel chickens has been seen year round (Day and 
Stark, 2000).  The ideal sentinel bird is a species that is uniformly susceptible to 
infection, resistant to disease, rapidly develops a detectable immune response, easily 
maintained, presents negligible health risks to handlers, does not contribute to 
transmission cycles, and seroconverts to the target pathogen prior to the onset of disease 
outbreaks in the community (Komar, 2001).  Chickens are often chosen as sentinels 
because they exhibit most of these characteristics (Langevin et al, 2001).  Domestic 
chickens are one of the most widely used sentinel animals for the detection of 
arboviruses.  However, one ideal captive avian sentinel for all arboviruses may not truly 
exist (CDC, 1993).  The use of sentinel chickens allows sentinel data to be collected in 
real time and assesses the relative risk of mosquito-borne arbovirus transmission (Day, 
2001).     
Florida Sentinel Chicken Program 
 The Florida Sentinel Chicken Arboviral Surveillance Network was established in 
1978 following a widespread rural epidemic of SLEV in central Florida (Day and Stark, 
1996).  This surveillance program has formed statewide partnerships between the Florida 
Department of Health, local mosquito management districts, the Department of 
Agriculture and Consumer Services and other governmental agencies that monitor 
arboviral activity.  Florida guidelines recommend that sentinels be placed in cages near 
potential mosquito breeding grounds and that all chickens in a flock are sampled weekly 
(FBE & FDOH, 2000).  Seroconversion (development of measurable antibodies after 
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exposure to an infectious agent) rates in sentinel chickens serve as indicators and 
predictors of arbovirus transmission and identify high risk areas (Komar, 2001).   
Florida’s sentinel chicken surveillance program serves as an excellent early 
warning system not only for endemic diseases like SLEV, but also allows for the 
detection of new or re-emerging diseases by presence of viral antibodies (Blackmore et 
al, 2003).  It is very important to use surveillance data to differentiate between the 
presence of SLEV and WNV since SLEV is endemic to Florida.  An increase in arboviral 
activity above historical baseline levels immediately impacts vector control strategies and 
may warrant medical alerts to warn the population.  In 2005, there were 3,081 individual 
sentinel birds assayed (47, 542 serum samples). 414 chickens developed antibody to 
WNV (10.9%), 5 to SLEV (0.3%), 414 (9.0%) to Eastern Equine Encephalomyelitis virus 
(EEEV) (9.0%), and 108 to Highlands Jay virus (HJV) (2.84%)  (Stark, 2005).  
Serological Detection Methods 
Serological detection methods are complex due to close antigenic relationships 
between the flaviviruses.  Specialized diagnostic tests are required to differentiate 
between viruses, especially cross-reactions between WNV and SLEV, such that acute and  
convalescent paired sera samples from patients are often necessary to analyze antibody 
response (Petersen and Roehrig, 2001).  Current serological detection methods include 
Hemagglutination Inhibition Antibody Test (HAI), IgM Antibody Capture Enzyme-
Linked Immunosorbent Assay (MAC-ELISA), IgG ELISA, Indirect Fluorescent 
Antibody Test (IFA) and Plaque Reduction Neutralization Test (PRNT).   
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Hemagglutination Inhibition Test (HAI) 
Hemagglutination is a characteristic harbored by most arboviruses, and 
hemagglutinins have specific requirements for type of erythrocyte and pH (Sabin & 
Buescher, 1950; Sabin, 1951; Chanock & Sabin, 1953, 1954a, 1954b; Sweet & Sabin, 
1954).  Arboviruses agglutinate goose erythrocytes and antiviral antibodies in sera can 
specifically inhibit the hemagglutination reaction such that this test can be utilized for 
diagnostic purposes (Clarke & Casals, 1958).   
Suckling mice are inoculated with virus, and the brain tissue, which contains high 
titers of virus, is harvested.  The brains are used as antigens in the HAI assay after 
processing with sucrose-acetone.  Acetone extraction and treatment of sera with 
protamine sulfate remove non-specific lipoprotein inhibitors and broadens the pH range 
for hemagglutination activity.  The test is performed with treated sera that are serially 
diluted and incubated overnight with a standardized amount of antigen allowing for 
antigen-antibody binding.  The presence of antibody bound to the antigen inhibits the 
agglutination of the goose red blood cells as indicated by a button of red cells showing 
the inhibition of agglutination (Clarke & Casals, 1958).  The endpoint of the HAI activity 
is the reciprocal of the highest serum dilution showing complete inhibition of 
hemaglutination (Lennette et al, 1995).  
The HAI test is inexpensive and easy to perform, used for a variety of etiologic 
agents, and can test large numbers of specimens at one time.  Another benefit of this test 
is that it is not restricted to species type.  Currently, the HAI test is used as a screening 
tool to detect the presence of antibodies to flaviviruses and alphaviruses in sentinel 
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chicken sera by the Florida Department of Health, Bureau of Laboratories.  The HAI test 
is cost-effective, reproducible, has a high sensitivity, and is useful for analyzing the 
50,000 chicken sera received each year for testing.  
However, the HAI test cannot be performed rapidly, especially when large 
numbers of sera are tested.  Results may not be reported for a week and may effect local 
agencies response time to initiate or intensify control measures (Olsen et al, 1991).  
Cross-reactivity within a virus group (SLEV & WNV) is common and can complicate 
interpretation of HAI test results.  The HAI test does not distinguish between antibodies 
to SLEV and to WNV, and for this reason this test is only used as a screening tool.  
Positive sera are then confirmed using other serological methods.   
IgM Antibody Capture Enzymed-Linked Immunoasorbent Assay (MAC-ELISA)   
 The MAC-ELISA test can distinguish between viruses by indicating the infecting 
strain rather than just virus group.  The immunoglobulin M antibody capture enzyme-
linked immunosorbent assay (MAC-ELISA) is a confirmatory test used to detect IgM 
antibodies to WNV and SLEV (Martin et al, 2000).  Elevated levels of IgM usually 
indicate recent exposure to antigen or a recent infection (Benjamini et al, 2000).  This is 
very important in determining current and increased arboviral activity.   
 The MAC-ELISA has proven to be an excellent technique for measuring IgM 
antibodies in response to viral infection (Duermeyer et al, 1979; Hofmann et al, 1979; 
Schmitz et al, 1980; Roggendorf et al, 1981; Burke & Nisalak, 1982; Jamnback et al, 
1982; Monath et al, 1984; Olson et al, 1991; Martin et al, 2000; Johnson et al, 2003).  
This standardized diagnostic method allows for a consistent rapid approach for 
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monitoring arboviral disease but is restricted by species type (Martin et al, 2000).  The 
MAC-ELISA is very advantageous as it reduces the need for a convalescent-phase serum 
which may be hard to obtain (Schmidt & Emmons, 1989).  
The MAC-ELISA test is performed as follows: anti-species IgM capture antibody 
(i.e. chicken) is coated on 96 well microplates, and the wells are blocked with milk to 
decrease nonspecific background absorbance.  Serum from the animal species is added 
(sentinel chicken sera) followed by non-infectious viral antigen.  The presence of antigen 
is detected using an enzyme-conjugated anti-species antibody that interacts with a 
chromogenic substrate to generate a colorimetric result (Martin et al, 2000).   
The MAC-ELISA is very sensitive and specific.  One shortcoming is that the  
MAC-ELISA is a two day test that requires about 4 hours of hands-on time for a 
40-sample test (Johnson et al, 2005).  Since the ELISA is a confirmation test the number 
of sera tested is greatly reduced from the amount assayed in the HAI.     
Plaque Reduction Neutralization Test (PRNT) 
 The Plaque Reduction Neutralization Test (PRNT) is by far the most sensitive and 
specific assay.  It can be used with sera from any animal species and is considered to be 
the gold standard of reliability.  Sera that are negative or equivocal in the MAC-ELISA 
are tested in the PRNT, which serves as the final confirmatory test.  The standard PRNT 
is performed in Vero (African green monkey kidney) cell cultures and utilizes live 
infectious virus.  If neutralizing antibody, resulting from viral infection or immunization, 
is present in a serum sample it will prevent the virus from infecting Vero cells.  Plaques 
form as colorless round areas where the cells have been killed by the virus.  A reduction 
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in number of plaques in the presence of a serum sample, when compared to the controls, 
is indicative of neutralization (Schmidt & Emmons, 1989).   
 A drawback of PRNT is that it uses live infectious virus, expensive, and takes at 
least two weeks to obtain confirmed results.  The PRNT requires precision in pipetting 
and must be performed under stringent biosafety requirements (Beaty et al, 1989).  
This described series of serological assays (HAI, ELISA, PRNT) may take over 
three weeks to generate a final result.  A more rapid and equally sensitive test to replace 
these current serological methods would be of benefit in decreasing turnaround time to 
initiate prevention strategies and early warning systems in a timely manner.   
Microsphere-based Immunoassays (MIAs) 
  Microsphere-based immunoassays (MIAs) are increasingly popular as a 
serological option for laboratory diagnosis of many diseases (Kellar et al, 2001).  The 
MIA technology merges the concepts of enzyme-linked immunosorbent assay (ELISA) 
and flow cytometry.  While the full potential of this approach has only been realized 
recently, microspheres and flow cytometry have had a long history (Vignali, 2000).  In 
1981, fluorescent labeled latex particles were used in the measurement of phagocytosis 
by neutrophils and macrophages (Dunn and Tyrer, 1981).  A year later, fluorescent beads 
were used as the standard for counting cells in the blood (Stewart and Steinkamp, 1982).   
Monoclonal antibodies coupled to beads gave rise to the idea that microsphere-based 
flow cytometric assays could be a viable alternative to the microtitre plate-based ELISA 
(Vignali, 2000).   
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An early attempt to use the microsphere-based flow cytometric technique to 
diagnose disease was utilized in an assay designed to quantify human IgG in sera.  
However, this study was not very successful as it was performed without any washing 
steps (Lisi et al, 1982). Since then, a number of MIA assays have been used to 
successfully measure antibodies against Helicobacter pylori (Best et al, 1992), hepatitis C 
virus (McHugh et al, 1997), immunoglobulin and immune complexes (McHugh et al, 
1986; Syrjala et al., 1991; Labus and Petersen, 1992), and phospholipids (Stewart et al, 
1993).  In some instances these assays were more sensitive than the conventional ELISA 
and could resolve indeterminate clinical samples (Vignali, 2000; McHugh et al, 1997).  A 
multiplex cytokine assay has also been developed to detect 15 different cytokines 
simultaneously (Jager et al, 2002).  All of these assays utilized the Bio-Plex instrument 
(Bio-Rad Laboratories, Hercules, CA). 
The Bio-Plex system combines the principle of immunoassay with Luminex 
fluorescent-bead-based technology (Jager et al, 2002).  The Luminex system merges 
ELISA and flow cytometry and involves the detection and analysis of a reaction attached 
to microspheres or beads (Johnson et al, 2005).  The carboxylated surface of the bead 
allows for binding to many different biological agents.  Proteins, oligonucleotides, 
polysaccharides, lipids, antibodies, and small peptides have been adsorbed or chemically 
coupled to the surface of microspheres to capture analytes that are subsequently measured 
by a fluorochrome-conjugated detection molecule (Kellar & Iannone, 2002).  A 
possibility of 100 different bead sets (produced by the Luminex Corporation, Austin, 
Texas) allow for a single small volume of sample to be tested for several different 
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parameters at one time.  Each bead set contains a mixture of red and infrared dyes and 
possesses its own unique spectral properties.  This feature allows multiple bead sets to be 
simultaneously used in one testing well (Waterboer et al, 2005). 
The Luminex software has the ability to identify each individual bead set by the 
combination of two lasers.  The red laser excites the red and infrared dyes within the bead 
set which allows it to classify each bead set.  The green laser measures the florescence 
associated with the binding between the bead and the fluorochrome-conjugated detection 
molecule.  A main advantage of this methodology is the ability to multiplex by testing 
many different biological agents simultaneously and the speed at which it can be 
accomplished (Waterboer et al, 2005).  A single small volume of sample can generate a 
large amount of information from one single assay.   
MIAs have the potential to be especially applicable in arbovirus serology because 
viruses of the same genus can share similar formats (Johnson et al, 2005).  One study 
conducted by Wong et al. (2003a) shows the ability of MIAs to detect antibodies to 
flavivirus E proteins in human sera.  This method involves a recombinant WNV envelope 
(E) protein antigen covalently coupled to microspheres (beads).  The beads are incubated 
with human serum or cerebral spinal fluid (CSF) and antibodies bound to the E-protein 
antigen are detected with a fluorescently labeled anti-human immunoglobulin antibody.  
Flaviruses (especially WNV and SLEV) are antigenically similar and related in structure 
and contain the E protein.  For this reason, this assay can only detect antibodies to the 
group flavivirus, and cannot differentiate between WNV and SLEV.  High cross-
reactivity of the E protein among flaviviruses limits the specificity of the assay and a 
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confirmation test is needed to identify the infecting virus (Wong et al, 2003).  A later 
study by Wong et al. (2003b) used similar methodology to target nonstructural protein 5 
to differentiate WNV infection from Dengue and SLEV infection, and from flavivirus 
vaccination.  Wong identified that nonstructural protein 5 is less cross reactive than the 
envelope protein, and has the ability to discriminate a WNV infection from SLEV and 
Dengue (Wong et al, 2003b). 
A recent study by Johnson et al has shown the ability of the MIA to detect IgM 
antibodies to WNV and SLEV in human sera (2005).  This duplex method uses a 
flavivirus group-reactive monoclonal antibody coupled to two different bead sets.  The 
use of this monoclonal antibody allows for different types of antigen to be attached to the 
different bead sets.  Human serum is added and detection of virus specific IgM antibody 
is done with a single primary antibody (Anti-human IgM) that is conjugated to the 
detection molecule phycoerythrin.  These duplex MIA results compared favorably to 
those of the PRNT and MAC-ELISA.  An advantage of this method is that it only takes 
3.5 hours to complete a 40 sample plate test and several plates can be tested within one 
day.  The duplex MIA represents a significant improvement over the way in which WNV 
and SLEV serology is currently being performed, especially with respect to decreased 
turn-around time and the generation of a single result (Johnson et al, 2005). 
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Objectives 
 
Rapid and accurate West Nile virus serological testing is a public health priority 
prompted by the dramatic increase in WNV infections in the United States, and by the 
evidence that the virus can be transmitted by blood and organ donations (Wong et. al, 
2003a).  The use of sentinel chickens for surveillance of arbovirus transmission is well 
established.  The Florida sentinel chicken program serves as a powerful tool for the 
detection of arbovirus transmission and identifies prevention and control strategies that 
should be implemented (Blackmore et al, 2001).   
Currently, sentinel chicken sera are tested using three different serological 
methods.  The HAI assay is used as a screening tool, MAC-ELISA as a confirmatory test, 
and the PRNT as the gold standard final confirmatory test.  The HAI is very sensitive 
although it uses group antigens so that closely related viruses often cross-react.  MAC-
ELISA is a much more sensitive and specific assay that can identify the infecting virus, 
but it is limited by species specific reagents.  The PRNT is the most sensitive and specific 
assay, but it is very expensive, a use live infectious virus, and is labor intensive. The 
combination of these three serological methods takes 2 to 3 weeks before participating 
counties can receive confirmed results.  The MIA test has been shown to be just as 
sensitive and specific as the MAC-ELISA and PRNT when testing human sera, but has 
several advantages over these traditional serological assays.   
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The hypothesis of this study is that a MIA can be developed (based on the method 
used by Johnson et al for human sera, 2005)  that is as sensitive and more specific than 
current serological screening methods to detect IgM antibodies to WNV and SLEV in 
sentinel chicken sera.  The development of an MIA to detect IgM antibodies in sentinel 
chicken sera will decrease turn-around time for accurate results and allow prevention and 
control measures to be implemented in a more timely manner.  The MIA has the potential 
and capability to handle a large number of sera for a sentinel surveillance program.  
This study has three specific aims: 
1) To design and validate a protocol for a microsphere-based immunoassay to 
detect IgM antibodies to WNV and SLEV in sentinel chicken sera.   
2) To determine the sensitivity, specificity, positive predictive value, and 
negative predictive value of the assay compared to the MAC-ELISA and HAI 
tests.  
3) To determine a cost and time analysis comparing the current series of 
serological detection methods to the adapted IgM MIA.  
The overall goal of this study is to enhance public health by improving current 
serological detection methods that are used for the surveillance of WNV and SLEV in 
sentinel chickens.    
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Materials and Methods 
Sentinel Chicken Sera Submission and Processing 
Sentinel chicken sera are received on a weekly basis at the Florida Department of 
Health, Tampa Branch Laboratory as part of Florida’s sentinel chicken surveillance 
program.  A total of 3,081 adult sentinel chickens were maintained at sites throughout the 
state of Florida and 47,542 serum samples were submitted between 1/01/2005 to 
12/31/05.  Upon submission, samples were screened for the presence of antibody to 
flavivirus (SLE) and alphavirus (EEE) group antigens with the hemagglutination 
inhibition antibody test (HAI).  Sentinels that were flavivirus group positive for the first 
time were assayed using the IgM antibody capture enzyme-linked immunosorbent assay 
(MAC-ELISA) and stored at 40C for future MIA testing. Additional HAI negative sera 
(titer < 10) were also stored for future analysis (Figure 1).  
Sample Selection and Serum Specimens 
A total sample size of 368 sentinel chicken sera was selected for the microsphere-
based immunoassay to detect IgM antibodies to WNV.  This was determined using the 
sample size calculator designed by Cameron and Baldock (1998) based upon a population 
size of 3,081 individual sentinel chickens, 80% expected sensitivity and specificity, 
12.1% expected prevalence (based on annual historical data), level of significance (α = 
0.05), and power of 95% 
(http://www.ausvet.com.au/content.php?page=res_software#freecalc, 1998).  
Figure 1 Flowchart Algorithm for Sentinel Chicken Sera Testing.  Sentinel chicken  
sera were first tested in the HAI antibody test with flavivirus group antigen.          
Sera were confirmed using the MAC-ELISA with WNV and SLEV antigen.      
  MAC-ELISA negative or equivocal sera were tested in the PRNT.  All sera  
  samples were tested in the MIA to detect IgM antibodies to WNV and SLEV.    
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A total of 385 sentinel chicken sera were assayed in the MIA for WNV infection 
and SLEV infection.  273 flavivirus group positive sera samples from the HAI assay (titer 
> 1:10 and reactive) were confirmed WNV positive in the MAC-ELISA (P/N > 2.0) and 
tested in the MIA assay.  An additional 36 samples were also HAI flavivirus positive but 
tested negative or equivocal in the MAC-ELISA (P/N < 2.0) and were assayed in the 
PRNT and the MIA. 76 HAI negative samples (titer <10) were tested in the MAC-
ELISA, PRNT and MIA (Figure 2).  
The prevalence of SLEV is very low leading to a large predicted sample size of 
950 sentinel chickens.  This was determined using the same sample size calculator as 
above, based upon an average population size of 2,820 individual sentinel chickens from 
five years (1999, 2000, 2003, 2004, and 2005), 80% expected sensitivity and specificity, 
7.3% expected prevalence, level of significance (α = 0.05), and power of 95% 
(http://www.ausvet.com.au/content.php?page=res_software#freecalc, 1998).  The 
expected prevalence was determined based upon annual historical prevalence data from 
the Florida Department of Health, Tampa Branch Laboratories.  A total of 424 sentinel 
chicken sera from multiple years were assayed in the microsphere-based immunoassay 
for SLEV (Table 1).  In 1999, 6 sera were HAI flavivirus group positive (titer > 1:10) and 
confirmed in the PRNT for SLEV.  28 sentinel chicken sera were HAI flavivirus group 
positive and confirmed SLEV positive in the MAC-ELISA in 2000.  A total of 5 sera 
from 2003 were HAI flavivirus group positive and confirmed MAC-ELISA positive for 
SLEV.  One sample from 2004 was HAI flavivirus group positive and SLEV confirmed  
 
 
Figure 2 Flowchart Algorithm for Sentinel Chicken Sera Testing for Antibodies to WNV.   
  Sentinel chicken sera were first tested in the HAI antibody test with flavivirus  
  group antigen. Sera were confirmed using the MAC-ELISA with WNV antigen.  
  MAC-ELISA negative or equivocal sera (Neg or Equiv) were tested in the  
  PRNT. All sera samples were tested in the MIA to detect IgM antibodies to     
  WNV.    
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23  
Sentinel Chicken Sera
(385) 
HAI Positive 
(309) 
HAI Negative 
 (76) 
 MAC-ELISA 
(309)  
MAC-ELISA 
(76)  
Positive 
(273) 
Neg or Equiv 
(36) 
Positive 
(6) 
Neg or Equiv  
(70) 
PRNT 
(36) 
Microsphere-based 
Immunoassay 
(6) 
PRNT 
(70) 
Microsphere-based 
Immunoassay 
(273) 
Microsphere-based 
Immunoassay 
(36) 
Microsphere-based 
Immunoassay 
(70) 
Sentinel Chicken Sera Testing Algorithm for West Nile Virus 
24  
Table 1 Illustration of Sentinel Chicken Sera from Multiple Years Tested for the Presence  
 of IgM Antibodies to St. Louis Encephalitis Virus.  Chicken sera were classified  
 into four different groups: flavivirus (Flav.) hemagglutination inhibition antibody  
 test positive (HAI +) and MAC-ELISA positive (ELISA +), HAI + and ELISA  
 negative (-), HAI - and ELISA -, and HAI + and PRNT +.     
 
 
 
 St. Louis Encephalitis Chicken Sera 
Year Flav. HAI +, ELISA + 
Flav. HAI +, 
ELISA - 
Flav. HAI -, 
ELISA -,  
Flav. HAI +, 
PRNT + 
1999 0 0 0 6 
2000 28 0 0 0 
2003 5 0 0 0 
2004 0 0 0 1 
2005 3 305 76 0 
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positive by the PRNT.  308 sera were HAI flavivirus group positive: 3 sera were 
confirmed in the MAC-ELISA for SLEV and 305 were MAC- ELISA negative in 2005.  
76 HAI negative sera were tested and confirmed negative for SLEV in the MAC- ELISA.  
All negative or equivocal sera in the MAC-ELISA were tested in the PRNT (Figure 3). 
All sentinel chicken sera in this study were tested for the presence of IgM 
antibodies to WNV and SLEV simultaneously in the microsphere-based immunoassay. 
Serum Analysis 
HAI, MAC-ELISA, and PRNT Assays 
 Sentinel chicken sera were received each week and centrifuged at 2000 xg for 10 
min, 40C (Beckman Coulter, Allegra 6R) for testing in the hemagglutination inhibition 
antibody test (HAI).  Samples were treated with protamine sulfate (Holden et al., 1966), 
acetone extracted and assayed by the method of Clarke and Casals (1958) in microtiter 
plates.  Antigens (TBH 28 SM11 11/5/04) for the HAI antibody test were prepared from 
suckling mouse brains by the sucrose-acetone-extraction (Schmidt, 1979) and 
betapropriolactone-inactivation (Sever et al, 1964) method.  Sentinel chicken sera that 
were flavivirus group positive for the first time in the HAI assay were tested for virus-
specific IgM antibodies to WNV or SLEV in the MAC-ELISA, using the protocol 
developed by Martin et al., 2000).   
  
 
 
 
 
 
 
Figure 3   Flowchart Algorithm for Sentinel Chicken Sera Testing for Antibodies to  
     SLEV.  Sentinel chicken sera were first tested in the HAI antibody test with  
     flavivirus group antigen. Sera were confirmed using the MAC-ELISA with  
    SLEV antigen. MAC-ELISA negative or equivocal sera (Neg or Equiv) were  
    tested in the PRNT. All sera samples were tested in the MIA to detect IgM  
    antibodies to SLEV.    
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Antigens used in the MAC-ELISA included SLEV viral mouse brain antigen 
(TBH-28, cat# M29797) and normal antigen (for WNV and SLEV, cat# M29714) that 
were obtained from the Centers for Disease Control and Prevention (CDC), Fort Collins, 
Colorado. West Nile viral antigen was prepared by sucrose-acetone extraction of suckling 
mouse brain at the Florida Department of Health, Tampa Branch Laboratory (WN EG101 
SMB SA-antigen, lot# TBL 1, 2/6/03).  Flavivirus group peroxidase conjugated 
monoclonal antibodies (6B6C-1) (Cat# Vs2372, lot# 99-0074L) were obtained from the 
CDC, Atlanta, Georgia. 
 Briefly, the MAC-ELISA was performed as follows: capture antibody, goat anti-
chicken IgM, lyophilized (MP Biomedicals, cat# 64395, lot# 8155H), was diluted 1:1000 
in carbonate-bicarbonate buffer (0.015M sodium carbonate, 0.035 M sodium bicarbonate, 
pH 9.6).  Viral antigens were diluted in wash buffer (0.05% Tween 20 PBS solution), 
WNV + antigen (1:160) and SLEV + antigen (1:800).  Chicken sera and test controls 
were also diluted in wash buffer (1:400).  Sera were assayed in duplicate, known positive 
and negative control chicken sera were included on each test plate.  There were separate 
assay plates for each antigen tested (WNV and SLEV).   
MAC-ELISA results were determined by calculating positive to negative ratios 
(P/N).  The P/N value for test serum was computed by dividing the mean Optical Density 
(OD) of the test serum with viral antigen by the mean OD of the negative control serum 
with viral antigen.  A specimen was considered positive for IgM antibodies if the P/N > 
2.  A specimen was considered to have an equivocal result if the P/N value was in the 
range of 1.6 to 1.999.  The validity of each sample was determined by dividing the OD of 
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the test sera with viral antigen by the OD of the test sera with negative antigen.  Sera 
were considered valid if this value was > 2.    Sera samples positive for IgM antibodies to 
WNV or SLEV were reported positive for infection.  IgM-negative or equivocal chickens 
were tested in the PRNT to detect neutralizing antibody titers, using a previously 
described method (Schmidt, 1979; Beaty et al, 1989). Both positive and negative sera 
were then tested in the microsphere-based immunoassay.    
Microsphere-based Immunoassay (MIA) 
 Standardization of Microsphere-based Immunoassay 
The Microsphere-based immunoassay developed for this study was based on the 
method used by Johnson et al (2005) for the detection of IgM antibodies to WNV and 
SLEV in human sera, and adapted to test sentinel chicken sera in this study.  The clinical 
MIA used to assay human sera required a single anti-human IgM phycoerythrin 
conjugated primary antibody.  This type of antibody was not available for chicken sera; 
therefore, a two step combination of a primary antibody followed by a secondary 
antibody was used to enhance detection.  The secondary antibody was attached to the 
detector molecule and measured the detection of IgM antibodies to WNV and SLEV in 
sentinel chicken sera.  A total of 20 MAC-ELISA WNV positive sera, 8 SLEV positive 
sera, and 20 negative sera were initially tested in the MIA to determine the optimal 
concentrations for primary and secondary antibody, antigen/bead set mixtures, and test 
serum samples. Several dilution series were performed for each parameter individually 
(Table 2).  Varying dilutions of the primary and secondary antibody were tested in 
combination with sentinel chicken sera, which was diluted 1:400 in MIA running buffer 
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(Table 3). Optimal concentrations were 2μg/ml for the primary antibody, 1 μg/ml for the 
secondary antibody, 1:10 dilution for the antigen/bead set mixtures, and a 1:400 dilution 
for the sentinel chicken sera samples.  These concentrations were then used to test all 
specimens. 
The clinical MIA developed by Johnson et al, (2005) depleted the human sera of 
IgG prior to testing the human sera for the presence of IgM antibodies.  A total of  20 
MAC-ELISA WNV positive sera, 10 SLEV positive sera, and 20 negative sera were 
depleted of IgG using protein G sepharose following the manufacturer’s instructions 
(Amersham Biosciences, cat# 17-0618-01) prior to tested in the MIA.  These sera were 
also tested without depletion of IgG.  
Flavivirus Monoclonal Antibody Coupled Microspheres (Bead Sets) 
 Two different bead sets were chemically coupled to a flavivirus group reactive 
monoclonal antibody (6B6C-1) and were purchased from Radix, Biosolutions, 
Georgetown, Texas.  One bead set was used for WNV (bead set 32-6B6C-1. lot# 
C050330rG-11) and another bead set used for SLEV (bead set 57-6B6C-1, lot# 
C050330RG-12).  Either control or positive viral antigens were then added to these 
monoclonal antibody coupled bead sets in order to perform the microsphere-based 
immunoassay.  Negative control antigens were necessary to ensure that nonspecific 
factors or inhibitors were not present in the test sera.     
Addition of Antigen to Bead Sets 
In two separate 4ml brown bottles (Nalgene, HDPE lot #2004-915), West Nile 
viral protein antigen, E-prM protein expressed in COS-1 cells (obtained from CDC Fort  
 
 
Table 2   Standardization of Microsphere-based Immunoassay Reagents for the Detection  
   of IgM Antibodies to WNV and SLEV in Sentinel Chicken Sera.  Each reagent  
   was tested in duplicate at the specified dilution series for sera and antigen/bead  
   set mixtures to optimize the performance of the MIA.  For example, sera were  
   diluted at a 1:160 and assayed with each dilution of the antigen/bead set  
   mixtures (1:5, 1:10, 1:20).  The concentration of the primary and secondary   
   antibody was held constant at 2 μg/ml and 1 μg/ml respectively.   
 
 
 
Microsphere-based 
Immunoassay Reagents 
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Sera Antigen Beadset 
 
1:160 
 
1:5, 1:10, 1:20 
 
1:320 1:5, 1:10, 1:20 
 
1:400 1:5, 1:10, 1:20 
 
1:640 1:5, 1:10, 1:20 
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1:1280 1:5, 1:10, 1:20 
 
 
Table 3  Standardization of Primary and Secondary Antibodies in Combination to  
  Optimize the Detection of Viral Specific IgM Antibodies in Sentinel Chicken      
  Sera. Different concentrations of each antibody were combined and tested    
  against sentinel chicken sera (1:400 dilution in MIA running buffer) to minimize  
  nonspecific reactions that influence fluorescence intensity.  The concentration of  
  the antigen/bead set mixture was also held constant at a 1:10 dilution. 
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Antibody Concentrations ( μg/ml) 
 
Primary Antibody  Secondary Antibody 
(Goat Anti-Chicken IgM) (PorcineAnti-Goat IgG-PE)
 
Combination 1 
  
4 2 
 
Combination 2 
  
2 2 
 
Combination 3 
  
2 1 
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Collins-Focus technologies, lot# 02-VPA-RD 10274) and negative COS-1 antigen 
(obtained from CDC Fort Collins, 2005 lot) were separately coupled to bead set 32  
containing the 6B6C-1 monoclonal antibody (6B6C-1/beadset 32) in MIA running buffer 
(PBS 1% BSA, Sigma cat # P3688) [see Table 4].  The mixture was incubated on a  
rotating labquake tube rotator (VWR cat # 56264-302) at room temperature for one hour 
and then stored for up to one month at 40C (Johnson et al, 2005).  St. Louis Encephalitis 
virus suckling mouse brain antigen (obtained from CDC, Fort Collins FC-M29 715-04-0, 
cat # 0057) and normal control suckling mouse brain antigen (negative antigen, obtained 
from CDC, Fort Collins, cat# 0006) were coupled separately to bead set 57 containing the 
6B6C-1 monoclonal antibody (6B6C-1/beadset 57) using the same procedure [see Table 
5].  The final concentration for each antigen/bead set mixture was 500 beads/μl (Johnson 
et al, 2005). 
Microsphere-based Immunoassay Protocol (Sentinel Chicken Sera) 
The microsphere-based immunoassay differs from the traditional ELISA format 
primarily in the type of plate used.  The 96 well filter plates are specifically developed for 
compatibility with bead-based assays (Millipore cat # MABVN1250, lot# F5HN65106).  
Individual wells are used as reaction vessels and allow for repeated incubations and 
filtrations using the vacuum manifold system (VWR cat# 16003-836).  The beads are 
trapped on the filter and are not removed during filtration. 
Serum samples, primary and secondary antibody, and antigen/bead set mixtures 
were diluted to their working concentrations (Tables 4, 5).  Sera, including positive and  
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Table 4 WNV Antigen Coupled Bead Set Sample Mix.  Reagents and volumes listed are  
       sufficient for 60 reactions.  The protein concentration of the WNV positive  
  recombinant antigen required the usage of a higher volume due to the nature of  
  the antigen.  
 
 
 
 
Reagent Volumes for Coupling Positive and 
Negative Viral Antigens to Bead Set 32 
 
 
 
 
Reagents 
 
WNV (+) Ag/6B6C-1*
 
 
WNV (-) Ag/6B6C-1*
 
 
WNV (+)  
Recombinant E-prM 
Antigen 
17.5 _________ 
 
WNV(-) Recombinant 
Antigen 
________ 15.5 
 
Bead set 32/6B6C-1 
 
50 50 
 
Running Buffer 
 
432.7 434.5 
  * Volumes for all reagents are in μl.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 SLEV Antigen Coupled Bead Set Sample Mix.  Reagents and volumes listed are  
 sufficient for 60 reactions 
 
 
Reagent Volumes for Coupling Positive and 
Negative Viral Antigens to Bead Set 57 
 Reagents 
  
SLE (-) Ag/6B6C-1 
 
SLE (+) Ag/6B6C-1 
 
 
SLEV (+) SMB Antigen 
 
5  _________ 
 
SLEV Normal Mouse 
Brain Antigen 
________ 5  
 
Bead set 57/6B6C-1 50  50  
 
 
Running Buffer 445  
 
  * Volumes for all reagents are in μl. 
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negative controls, were diluted in MIA running buffer (1:400).  Primary antibody, goat 
anti-chicken IgM serum lyophilized (MP Biomedicals, cat# 64395, lot# 8155H), was  
diluted to 2μg/ml in MIA running buffer.  Secondary antibody, porcine anti-goat IgG-
phycoerythrin (PE) (R&D Systems, cat# F0106, lot# LNG06), was diluted to 1μg/ml in  
MIA running buffer.  The antigen/bead set mixtures (6B6C-1/bead set 32/WNV+Ag, 
6B6C-1/bead set 32/WNV-Ag, 6B6C-1/bead set 57/SLEV+Ag, 6B6C-1/bead set 
57/SLEV-Ag) were also diluted in MIA running buffer (1:10).  Working dilutions were 
prepared the same day as the assay and kept on ice until use.  The bead/antigen mixtures 
and secondary antibody are light sensitive and were covered with aluminum foil.   
The left side of the plate was designated for positive viral antigen and the right 
side was for negative viral or normal antigen.  Each side included control sera in 
duplicate: WNV positive control serum, SLEV positive control serum, and negative 
control serum (Figure 4).  This allowed for 40 sentinel chicken sera to be tested on one 
plate at ambient temperature.   
MIA running buffer (100 μl) was added to each of the 96 wells and incubated for 
5 minutes.  Vacuum was applied to a manifold suctioning buffer from the wells.  The 
positive SLEV and WNV bead/antigen mixtures were combined and added to each well 
in the left side of the plate (viral antigen side).  Negative SLEV and WNV bead/antigen 
mixtures were combined and added to each well in the right side of the plate (Figure 5).  
The buffer was immediately removed by vacuum.  The beads were then washed twice 
with 100 μl of MIA running buffer.  Positive, negative, or test sera were added to each  
 
 
Figure 4 Plate Format of the Microsphere-based Immunoassay for Sentinel Chicken Sera,  
  Adapted from Johnson et al, 2005.  The plate was divided in half and the left  
  side contained WNV and SLEV viral antigens and the right side contained the  
  negative or normal WNV and SLEV antigens. 
 
 
                  Positive Viral Antigen    Negative Viral Antigen 
 
    WNV positive sentinel chicken control sera  
    
SLEV positive sentinel chicken control sera 
 
     SLEV/WNV negative control sera 
 
     Sentinel Chicken test sera 
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Figure 5 96-well Filter Plate Showing the Combination of WNV and SLEV Bead Sets. 
             WNV/6B6C-1/bead set 32 and SLEV/6B6C-1/bead set 57 were combined and  
  added to each well of the filter plate.  The left side of the plate contained WNV  
  and SLEV positive antigen bead set/mixtures and each well of the right side  
  contained WNV and SLEV negative antigen bead set/mixtures.  
 
 
               Positive Antigen Viral Antigen              Negative Viral Antigen 
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well in 50 μl aliquots of the working dilution and the plate was sealed with tape (Marsh 
Biomedicals, cat#1044-39-4) and covered with aluminum foil to protect the light  
sensitive beads.  The plate was placed on a plate shaker platform and rotated at 1100 rpm 
for 30 sec to re-suspend and mix the beads/sera in each well.  The plate shaker was then 
slowed to 300 rpm for 1 hour.   
After the one hour incubation, the wells were washed twice with 100μl of MIA 
running buffer using the vacuum manifold, and 50 μl of goat anti-chicken IgM antibody 
was added to each well.  The plate was placed on the shaker platform for 30 min.  After 
the 30 min incubation, the wells were washed twice with 100 μl of MIA running buffer, 
after which, 50 μl of secondary antibody was added to each well.  The plate was placed 
on the shaker for 30 minutes.  After this 30 minute incubation, the wells were vacuumed 
and washed twice with 100 μl of MIA running buffer.  After the second wash, 100 μl of 
MIA running buffer was added to each well of the plate.  The plate was placed on the 
plate shaker at 1100 rpm for 30 sec to resuspend the beads (Figure 6).  
 Detection of IgM Antibodies to WNV and SLEV 
 The Luminex instrument (BioRad (Bioplex) cat # 171-203060) was turned on at 
least 30 minutes prior to plate reading to warm up the lasers.  Start up and calibration 
steps on the instrument were performed following the recommended guidelines from the 
manufacturer (Bioplex Luminex).  After the machine was calibrated, sample information 
including plate format, and protocol set up were added into the Luminex system.  This 
protocol identified the two bead sets to be targeted (6B6C-1/32 and 6B6C-1/57) and the  
  
Figure 6 MIA Flowchart for Sentinel Chicken Sera  
Bead sets coupled with Monoclonal Antibody and +/- Ag
Addition of Sentinel chicken sera
Addition of 10 Ab Goat Anti- Chicken IgM
Incubate 30 min
Addition of 2o Ab Anti- Goat-PE
Incubate 30 min
Read Plate using Luminex System
Incubate for 1 hr  
Wash 2X (vacuum manifold)
Wash 2X (vacuum manifold)
Wash 2X (vacuum manifold)
Resuspension
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total sample volume.  The plate was then placed into the machine and read under these 
conditions.  
 The combination of two lasers within the Luminex machine simultaneously 
identified the individual bead sets and associated antigen-antibody binding reactions.  
The red laser detected the bead set (32 or 57) while the green laser detected and measured 
the median fluorescent intensity associated with the bond between the phycoerythrin (PE) 
molecule (secondary antibody) and the sample to antigen/bead set mixture (Figure 7).  A 
median fluorescent intensity (MFI) was given for each sample.  These MFI numbers were 
exported to a Microsoft Excel file for further analysis. 
Classification of the Microsphere-based Immunoassay Results  
 Classification was defined as the result of the WNV/ SLEV MIA for a sample 
based upon transformed data.  The median fluorescent intensity (MFI) for each sample 
was transformed into an adjusted value by dividing the MFI of the sample reacted on 
viral antigen by the MFI of the negative control on viral antigen for each plate.  Receiver 
Operator Characteristic (ROC) curves were used to define the optimal cut-off for the 
adjusted MIA values and further characterized the adjusted MFI as WNV positive, SLEV 
positive or negative.  These curves were generated using the Analyse-it Software, LTD (a 
Microsoft Excel add-in) to visually assess a diagnostic test's ability to discriminate 
between normal and abnormal subjects (i.e. chicken sera)  At each possible decision 
threshold,  a curve plotted the percentage of abnormal subjects correctly diagnosed (true 
positives) against the percentage of normal subjects incorrectly diagnosed as abnormal 
(false positives).  The ROC curve analysis determined the cutoffs for adjusted WNV and  
Figure 7 Illustration of the Luminex System’s Dual Laser Detection of IgM Antibodies to  
   WNV.  If antibody to WNV was present in the sera it bound to the bead set      
              coupled to the WNV viral antigen.  Binding was detected with the combination  
   of the green and red lasers of the Luminex machine.  This laser technology will  
   also detect SLEV antigen/bead sets that are also present in the same well.  
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SLEV MFI values based on sensitivity and specificity.  At each cut-off point, the ROC 
curve determines the amount of true positives, true negatives, false positives and false 
negatives expected.  The comparisons of true values were defined by the current testing 
algorithm.  For example, sentinel chicken sera that were HAI positive and MAC-ELISA 
positive were considered to have a positive true value.  Sera that were HAI positive, 
MAC-ELISA negative and PRNT positive had a true value of positive and sera that were 
HAI negative MAC-ELISA negative and PRNT negative were classified as true 
negatives.     
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Results 
As previously determined by the Cameron and Baldock sample calculator, a total 
of 368 sentinel chicken sera were calculated for the WNV sample size and 950 sera for 
the SLEV sample size for this study.  A total of 385 sentinel chicken sera were assayed as 
part of the WNV sample size. However, due to the low prevalence of SLEV, only 424 
sera were available for testing and thus did not meet the expected sample size of 950.  All 
sera were tested for viral antibodies to WNV and SLEV simultaneously using the 
microsphere-based immunoassay (MIA) developed for this study, and the ability of the 
assay to distinguish between the two viruses was evaluated.  Using two-by-two tables, the 
sensitivity, specificity, positive predicted value (PPV), and negative predicted value 
(NPV) were determined for each serological assay used to detect the presence of 
antibodies to WNV and SLEV (HAI, MAC-ELISA, MIA).  Results of the serological 
assays were compared to the true result as determined by the current testing algorithm.   
Univariate comparison of dichotomous outcomes in the HAI, MAC-ELISA, and 
MIA was performed using McNemar’s Test (Analyse It LTD, for Microsoft Excel).  
McNemar’s test is a statistical equivalency test in which the null and alternative 
hypotheses are reversed, thus looking for discordance.  A p value less than 0.05 indicates 
that the two testing methods being compared are not equivalent.  Kappa measure of 
agreement, Pearson’s Correlation, and Youden’s J, Discordance, and Concordance are 
statistical tests which look at equivalency and measure the association between variables 
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with dichotomous outcomes (Simple Interactive Statistical Analysis, Diagnostic 
effectiveness, http://home.clara.net/sisa/diaghlp.htm).  The Kappa measure of agreement 
takes on a value of zero if there is no agreement between tests, and a value of 1 if there is 
perfect agreement indicating the test always correctly predicts the outcome.  The Kappa 
statistic has the following characteristics: less than 0.4 poor agreement, 0.4 to 0.75 fair to 
good, and greater than 0.75 excellent agreement.  A correlation between the sensitivity, 
specificity, PPV, and NPV of the three serological assays with the prevalence of WNV 
per season and month were generated using Microsoft Excel.  Statistical analyses were 
performed with the assistance of Angela E. Butler, MSPH.           
IgG Depletion of Sentinel Chicken Sera 
 A total of 20 MAC-ELISA WNV positive sera, ten SLEV positive sera and 20 
negative sera were depleted of IgG (described above) and tested in the MIA.  These 
results were compared to the non-depletion results using a paired sample t-test (Microsoft 
Excel).  It was determined that there was no significant difference between depleted and 
non-depleted chicken sera (p-value for all the paired > 0.05).  As a result, all of the sera 
further analyzed in the MIA were not depleted of IgG before testing.       
Classification of the Microsphere-based Immunoassay Results 
 The raw median fluorescent intensity (MFI) values for the sentinel chicken sera 
reacted with viral antigen reached a maximum of 10,000 for antibodies to WNV and a 
maximum of 5,984.5 for antibodies to SLEV.  Negative controls reacted with viral 
antigen typically had MFI values less than 120 and negative controls reacted with 
negative antigen resulted in MFI values less than 100.  MFI values for positive controls 
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were approximately 4,000 for WNV and 2,000 for SLEV reacting with viral antigens and 
below 200 for negative antigens.  The raw MFI values were adjusted by dividing the MFI 
of the sample reacting with viral antigen by the MFI of the negative control reacting with 
viral antigen (MIA Adjusted Value) for each plate.  This adjusted value was then 
compared to the true value (determined by the current testing algorithm), using Receiver 
Operator Characteristics (ROC) curves to determine the optimal cut-off for the sentinel 
chicken sera.  The point on the curve corresponding to the best sensitivity and specificity 
that yielded the highest number of true positives and true negatives, and the lowest 
number of false positives and false negatives was selected.  Based on 92.8% sensitivity 
and 80% specificity the cut-off for a sample with antibodies to WNV was 1.74545 and 
greater (Figure 8).  This value represents the point on the curve (cut-off point) where the 
sensitivity, specificity, PPV, and NPV for the prediction of the true value was the highest.  
The cut-off for a SLEV positive sample was 3.73214 and greater, based upon 93.2% 
sensitivity and 92.2% specificity (Figure 9).  Samples with adjusted values below the cut-
off were classified as negative.  Since cross-reactivity was present among WNV and 
SLEV the sample was considered positive for the virus which had the higher adjusted 
MFI value or two or more times greater the adjusted MFI value.  For example, if a serum 
had a WNV adjusted MFI of 3.5 and a SLEV adjusted MFI value of 3.8, the sera would 
be considered positive for WNV since 3.5 is two times greater than 1.74545 and 3.8 is 
just slightly above the cut-off for SLEV (3.73214).   
 
  
Figure 8 WNV ROC Curve Illustrating the Determination of the WNV Cut-off Value  
  (1.74545).  The sensitivity, portrayed on the y axis, was plotted against 1-      
  specificity, x axis, to determine cut-off values corresponding to different   
  sensitivities and specificities.  The optimal cutoff for the detection of IgM     
  antibodies to WNV corresponding to high expected value of true positives and  
  true negatives and a low value of false positives and false negatives was  
  established with a sensitivity of 92.8% and specificity of 80%.     
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Figure 9 SLEV ROC Curve for the Determination of the SLEV Cut-off Value  
              (3.73214).  The sensitivity, portrayed on the y axis, was plotted against                  
              1- specificity, x axis, to determine cut-off values corresponding to different     
               sensitivities and specificities.  The optimal cutoff for the detection of IgM    
               antibodies to SELV corresponding to high expected value of true positives and  
               true negatives and a low value of false positives and false negatives was  
               established with a sensitivity of 93.2% and specificity of 92.2%.     
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Detection of Antibodies to West Nile Virus and St. Louis Encephalitis Virus   
Hemagglutination Inhibition Test (HAI)  
 Flavivirus 
 A total of 424 sentinel chicken sera were assayed in the HAI for the presence of 
antibodies to the flavivirus group (WNV & SLEV) and 351 sera were flavivirus group 
positive.   The HAI correctly classified 338 sera as flavivirus group positive and 
misclassified 13 sera as flavivirus group negative.  A total of 73 negative sentinel chicken 
sera were assayed using the HAI and 23 were correctly classified as flavivirus group 
positive. 
 Comparison of these two results in a 2 X 2 table yielded a 93.6 % sensitivity, 79% 
specificity, 96% PPV, and 68% NPV for the detection of antibodies to the flavivirus 
group (Table 6).   
 West Nile Virus  
 From a sample size of 385 sentinel chickens, the HAI classified 312 sentinel 
chicken sera as having antibodies to the flavivirus group.  Compared to the true results, 
295 sentinel chicken sera were positive for WNV, 17 sera were flavivirus group positive,  
but negative for WNV:  3 of these sera were positive for antibodies to SLEV and 14 were 
negative for antibodies to both WNV and SLEV.  The HAI test identified 73 sera that 
were flavivirus group negative, but when further tested using the other serological 
methods (MAC-ELISA, PRNT) 22 sera were classified as having antibodies to WNV. 
 In a 2x2 comparison of these results, sensitivity of the HAI assay for the detection 
of antibodies to WNV is 93%, specificity 75%, PPV 94%, and NPV 70% (Table 7).  The  
 
 
Table 6 Detection of Antibodies to the Flavivirus Group Using the  
 Hemagglutination Inhibition Antibody Test.  This 2x2 table demonstrates  
 the ability of the MIA to classify chicken sera as flavivirus group positive    
 or negative. (Flav + or Flav. -).  Sensitivity, specificity, positive  
 predictive value and negative predictive value for the HAI for the  
 detection of antibodies to WNV were calculated based upon this 2x2  
 table. 
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ALGORITHM TRUE RESULT 
HAI 
Flav.+ Flav. - Totals 
Flavivirus+ 338 13 
 
351 
 
Flavivirus - 23 50 
 
73 
 
 
Sensitivity 
94% 
Specificity 
79% 
 
 
Totals 361 63 424 
 
 
PPV 94% 
NPV 68% 
 Table 7 Detection of Antibodies to Flavivirus Group in the HAI Compared to the  
WNV True Result.  The true results were determined by the current testing  
 algorithm.  Sensitivity, specificity, positive predictive value and negative   
 predictive value for the HAI for the detection of antibodies to WNV were  
 calculated based upon this 2x2 table. 
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ALGORITHM TRUE RESULT 
HAI 
WNV + WNV - Totals 
Flavivirus+ 295 17 
 
 
 
 312 
 
Flavivirus - 22 51 
 
73 
 
 
 
Sensitivity 
93% 
Specificity 
75% 
 
 
 
  
Totals 317 68 385 
  
 
 
 
 
 
 
 
 
PPV 94% 
  NPV 70% 
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detection of antibodies to WNV in sentinel chicken sera by the HAI compared to the true 
result was shown to be statistically equivalent by McNemar’s test (p value = 0.8238).  
The Kappa measure of agreement was 0.661 indicating a fair to good agreement. 
 St. Louis Encephalitis Virus 
 From a sample size of 424 sentinel chickens, the HAI classified 351 sentinel 
chicken sera as having antibodies to the flavivirus group.  Compared to the true results, 
43 sentinel chicken sera were positive for SLEV.  308 sera were negative for SLEV:  264 
were positive for antibodies to WNV and 44 were negative for antibodies to both WNV 
and SLEV.  The HAI test identified 73 sera that were flavivirus group negative, but when 
further tested using the PRNT, one serum was classified as having antibodies to SLEV.   
 HAI values were compared to the true result in a 2x2 table showing 98% 
sensitivity, 19% specificity, 12% PPV and 99% NPV for the detection of antibodies to 
SLEV (Table 8).  The detection of antibodies to SLEV in sentinel chicken sera by the 
HAI compared to the true result was shown to be non-equivalent by McNemar’s test (p < 
0.0001).  The Kappa measure of agreement was 0.041 indicating a poor agreement. 
IgM Antibody Capture Enzyme-Linked Immunosorbent Assay (MAC-ELISA) 
 West Nile Virus 
 A total of 302 sentinel chicken sera were classified as MAC-ELISA positive or 
equivocal (P/N > 1.6).  Compared to the true result, 290 sera were correctly classified as 
having antibodies to WNV (true positives) and 12 sera were classified as WNV  
 
 
 
 
Table 8 Detection of Antibodies to Flavivirus Group in the HAI Compared to the SLEV  
 True Result.  Sensitivity, specificity, positive predictive value and negative  
 predictive value for the HAI for the detection of antibodies to SLEV were  
 calculated based upon this 2x2 table. 
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ALGORITHM TRUE RESULT  
HAI 
SLEV + SLEV - Totals 
Flavivirus+ 43 308 
 
 
 
 
 
 351 
 
Flavivirus - 1 72 
 
73 
 
 
 
 
 
Sensitivity 
98% 
Specificity 
19% 
 
 
 
  
  
 Totals 44 380 424 
  
  
 
 
 
 
 
 
 
 
 
 
 
PPV 12% 
  NPV 99% 
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negative.  83 sera were classified as MAC-ELISA negative: 27 of these sera were 
identified positive for WNV and 56 sera were classified as negative for WNV in the 
PRNT (true negatives).   
 A 2x2 comparison of the MAC-ELISA results with the true results yielded a 
sensitivity of 91%, 82% specificity, 96% PPV and 67% NPV (Table 9).  The detection of 
antibodies to WNV by the MAC-ELISA as compared to the true result showed that they 
were statistically not equivalent by McNemar’s test (p = 0.0237). However, the Kappa 
measure of agreement was 0.679 indicating a fair to good agreement. 
 St. Louis Encephalitis Virus 
 43 sera were classified as MAC-ELISA positive or equivocal for SLEV (P/N > 
1.6) from a sample size of 424 sera.  Compared to the true results, 42 of these sera were 
correctly classified as SLEV positive and one serum was classified as negative.  381 sera 
were identified as MAC-ELISA negative: two of these sera were identified positive for 
SLEV and 379 sera were confirmed negative for SLEV in the PRNT (true negatives).  A 
2x2 table comparison of the SLEV MAC-ELISA result with the true results showed the 
sensitivity to be 95%, 99.7% specificity, 98% PPV, and 99% NPV (Table 10). The 
detection of antibodies to SLEV in sentinel chicken sera by the MAC-ELISA compared 
to the true results were shown to be statistically equivalent by McNemar’s test (p value = 
1.0000) and an excellent measure of agreement (K = 0.962). 
 
 
 
 
 
Table 9 Detection of Antibodies to WNV in the MAC-ELISA vs. the True Result.  
 Sensitivity, specificity, and predictive values were calculated based upon  
 this 2x2 comparison for the detection of antibodies to WNV.    
ALGORITHM TRUE RESULT 
MAC-ELISA 
WNV + WNV - Totals 
WNV+/ 
equiv 290 12 
 
302 
 
WNV - 27 56 
 
83 
 
 
Sensitivity 
91% 
Specificity 
82% 
PPV 96% 
 
 
385 Totals 317 68 
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  NPV 67% 
 Table 10 Detection of Antibodies to SLEV in the MAC-ELISA vs. the True Result.  
    Sensitivity, specificity, and predictive values were calculated based upon  
    this 2x2 comparison for the detection of antibodies to SLEV.    
 
 
ALGORITHM TRUE RESULT  
MAC-ELISA 
SLEV + SLEV - Totals 
SLEV+/ 
equiv 42 1 
 
 
 
43 
 
SLEV - 2 379 
 
381 
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Sensitivity 
95% 
Specificity 
99.7%  
PPV 98% 
 
 
  
Totals 44 380 424 
  
 
 
 
 
 
 
 
 
 
 
 
  NPV 99% 
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Microsphere-based Immunoassay (MIA)    
 West Nile Virus 
 Based on a sample of 385 sera, a total of 315 sentinel chicken sera were classified 
as WNV positive by Microsphere-based Immunoassay.  Compared to the true results, 306 
sera were identified as true positives for WNV (MIA positive and true result positive) and 
nine sera were determined to have a true negative result (MIA positive and true result 
negative).  70 sera were classified WNV negative by MIA. After comparison to the true 
result, 11 were WNV positive (false negative) and 59 were correctly classified as a true 
negative (MIA negative and true result negative).  The 2x2 comparison of the MIA 
results with the true results yielded a 96% sensitivity, 87% specificity, PPV 97%, and 
84% NPV (Table 11).  The detection of antibodies to WNV in sentinel chicken sera by 
the MIA as compared with the true results was statistically equivalent by McNemar’s test 
(p = 0.8238).  The Kappa measure of agreement was 0.937 indicating an excellent 
agreement.  
 St. Louis Encephalitis Virus  
 The MIA detected antibodies to SLEV in 45 of the 424 sentinel chicken sera 
assayed.  42 sera were correctly classified as SLEV positive (MIA positive and true result  
positive) and three were misclassified (MIA positive and true result negative).  A total of 
379 sera were negative for antibodies to SLEV in the MIA: 377 sera were correctly 
classified as negative (MIA negative and true result negative) and two sera positive MIA 
result and a negative true result.  The 2 x 2 comparison of the MIA results with the true 
results yielded 95% sensitivity, 99% specificity, 93% PPV, and 99% NPV (Table 12).   
 Table 11 Detection of Antibodies to WNV in the MIA vs. the True Result.  Sensitivity,  
   Specificity, and predictive values were calculated based upon this 2x2  
   comparison for the detection of IgM antibodies to WNV. 
 
ALGORITHM TRUE RESULT 
MIA 
WNV + WNV - Totals 
WNV+ 306 9 
 
315 
 
WNV - 11 59 
 
70 
 
 
Sensitivity 
96% 
Specificity 
87% 
 
 
385 Totals 317 68 
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PPV 97% 
  NPV 84% 
Table 12 Detection of Antibodies to SLEV in the MIA vs. the True Result.  Sensitivity,  
   Specificity, and predictive values were calculated based upon this 2x2  
   comparison for the detection of IgM antibodies to SLEV. 
 
 ALGORITHM TRUE RESULT 
MIA 
SLEV + SLEV - Totals 
SLEV+ 42 3 
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 45 
 
SLEV - 2 377 
 
379 
 
 
 
Sensitivity 
95% 
Specificity 
99% 
 
 
 
  
Totals 44 380 424 
  
 
 
 
 
 
 
 
 
 
 
 
 
PPV 93% 
  NPV 99% 
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Detection of antibodies to SLEV in sentinel chicken sera by the MIA compared with the 
true result was statistically equivalent by McNemar’s test (p = 1.0000) and showed an 
excellent measure of agreement (K = 0.937).  See Table 13 for a summary of statistical 
analyses.      
Correlation of Assay Sensitivity, Specificity, Positive Predictive Value, and Negative 
Predictive Value with Prevalence by Month for West Nile Virus 
  
 Sentinel chicken sera tested in this study, were grouped by month and sensitivity, 
specificity, PPV, NPV, and prevalence were calculated for each month.  The prevalence 
of each month was based upon historical sentinel chicken surveillance data.  A 
correlation between the prevalence and sensitivity, specificity, PPV and NPV for each 
assay (HAI, MAC-ELISA and the MIA) were conducted.  
 As prevalence of WNV infection increased, the sensitivity and NPV of the HAI 
remained consistent. However, as the prevalence increased, the specificity and PPV 
increased. Inversely, as the prevalence of WNV infection decreased in the sentinel 
chickens, the specificity and PPV of the HAI test decreased (Figure 10). 
 Correlation for the MAC-ELISA showed that as prevalence increased, the 
sensitivity and PPV remained consistent.  As prevalence decreased the NPV and 
specificity decreased however, the data contained extreme values causing the trend line 
not to have a good fit with the data points (Figure 11).  In comparison, as the prevalence 
increased the sensitivity and PPV remained consistent and the specificity slightly 
increased for the MIA.  The NPV slightly decreased as prevalence increased (Figure 12). 
   
 
Table 13 Summary of Statistical Analyses for the Hemagglutination Inhibition Assay  
    (HAI), MAC-ELISA (ELISA), and Microspehere-based Immunoassay (MIA).   
    McNemar’s Test, Pearson’s Correlation, Youden’s J, Kappa measurement of  
               agreement, Discordance, and Concordance were used to show the equivalence,  
     agreement and measure the association between variables with dichotomous  
     outcomes.  The HAI, ELISA, and MIA were compared to the True Results for  
    each statistical test.   
 
WNV Statistical Analyses 
Assay McNemar Pearson’s Youden’s J Kappa Discordance Concordance 
x2=0.013     0.684 
p=0.000 0.681 0.661 10.1% HAI 89.9%   p=0.522 
x2=0.039     0.662 
p=0.000 0.738 0.679 10.1% ELISA 89.9%   p=0.024 
x2=0.005      0.937 MIA 0.947 0.937 5.2% 94.8%   p=0.824 p=0.000 
SLEV Statistical Analyses 
  x2=0.724 
  p<0.000 
    0.135 
p=0.005 0.167 0.041 72.9% HAI 27.1% 
  x2=0.002     0.961 
p=0.000 0.952 0.962 0.7% ELISA 99.2%   p=1.000 
  x2=0.002       0.937 MIA 0.947 0.937 1.2%   p=1.000 p=0.000 
         
 
 
 
 
 
 
 
 
 
 
 
60  
98.8% 
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 A correlation of WNV prevalence with sensitivity, specificity, PPV and NPV by 
season was calculated and found to have extreme values and too few data points and was 
considered to be statistically invalid.  The month by month correlation was a better 
indicator to determine the influence of prevalence on the sensitivity, specificity, PPV and 
NPV for each serological assay.  The prevalence of SLEV was too low to calculate the 
correlation by month or season and more data was needed to determine a statistically 
valid result.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 Correlation of Prevalence with Sensitivity, Specificity, Positive Predictive 
     Value (PPV) and Negative Predictive Value (NPV) for the Hemagglutination  
      Inhibition Antibody Test (HAI).    
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Figure 11 Correlation of Prevalence with Sensitivity, Specificity, Positive Predictive  
     Value (PPV) and Negative Predictive Value (NPV) for the MAC-ELISA.   
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Figure 12 Correlation of Prevalence with Sensitivity, Specificity, Positive Predictive  
     Value (PPV) and Negative Predictive Value (NPV) for the Microsphere-based   
                 Immunoassay.   
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Discussion 
 This study describes the development of a Microsphere-based Immunoassay for 
the detection of IgM antibodies to WNV and SLEV in sentinel chicken sera. 
Seroconversion rates in sentinel chickens are useful predictors of arboviral transmission 
activity in an area and the success of a sentinel chicken surveillance program has been 
well-established in Florida (Blackmore, 2003). However, current serological detection 
methods may take up to 2-3 weeks to obtain a confirmed result. Unlike these assays, the 
MIA has the capability of testing a single small volume of sample for many parameters at 
the same time, dramatically decreasing turn-around-time by the laboratory (Johnson et al, 
2005). Consequently, the development and implementation of a MIA for the detection of 
antibodies to WNV and SLEV would be especially beneficial to a sentinel chicken 
surveillance program as a tool to rapidly identify arboviral transmission activity and 
implement vector control strategies.   
 The MIA previously described by Johnson et al (2005) was shown to be capable 
of detecting IgM antibodies to WNV and SLEV in human sera and cerebral spinal fluid 
(CSF). Further adaptation of this method is necessary for other species and several 
combinations of test reagents were assayed for this project.  In the clinical method, 
human sera were first depleted of IgG prior to testing.  After comparison of depleted and 
non-depleted chicken sera, it was shown that depletion of IgG was not necessary for 
testing of sentinel chicken sera.  This may have been due to the different types of IgG 
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found in human and chicken sera. The IgG present in chicken sera (also referred to as 
IgY) has a different molecular weight and structural properties than the human IgG 
(Johnson et al, 2005). 
 In addition, the adapted MIA for chicken sera required a combination of primary 
and secondary antibody to enhance detection, which differed from the single antibody 
requirement for the clinical MIA.  It was shown (in this study), that a combination of 
antibodies provided the least background (as measured by the luminex instrument) & 
detection was not possible with a single antibody.  However, the combination of two 
antibodies may have influenced the raw MFI values for each sample.  Although raw MFI 
values for positive controls reacting with viral antigen were similar to values shown in 
the clinical method, negative control raw MFI values were slightly higher in the MIA for 
sentinel chicken sera.  Consequently, a separate testing algorithm and protocol was 
developed for the chicken MIA, as the raw MFI results of the negative chicken sera were 
different from the human sera and significantly impacted analysis. 
 The statistical analysis program described by Johnson et al (2005) used MIA 
historical human data as a comparison group, and was developed for human sera only.  
Since the results indicated that chicken sera MFI values were different from the human 
sera MFI values, this statistical method was not used. In addition, historical data on 
chicken sera assayed by the MIA was not available for use as the comparison group.  
Unlike the statistical program used for clinical sera analysis, raw MFI values were not 
used to determine test validity.  Instead, raw MFI values and ROC curves were used in 
this study to generate the cut-off values.  Sera were then classified as WNV positive, 
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SLEV positive, or negative based on these adjusted MFI values and cut-off values.  These 
adjusted MFI values for chicken sera may provide historical or baseline data for a 
statistical analysis program to be developed in the future.  
 The HAI antibody test is used as a screening tool and detects antibodies to the 
flavivirus group.  The sensitivity, specificity, PPV, and NPV for the detection of 
antibodies to WNV was greater when using the MIA compared to the HAI (Figures 13 
and 14). Sensitivity of the HAI (98%) for the detection of antibodies to SLEV when 
compared to the true value was higher than the MIA (95%).  However, the specificity of 
the HAI was extremely low (19%) indicating that the HAI test alone does not distinguish 
between SLEV and WNV (Figure 15).  The low specificity is due to the fact that 70% of 
the flavivirus group positive sera were WNV positive, and not SLEV positive . The MIA, 
on the other hand, demonstrated a much higher specificity of 87%. The PPV (99%) and 
NPV (93%) of the MIA for the detection of antibodies to SLEV were higher than the 
HAI, 99% & 12%, respectively (Figure 16).  This illustrates the ability of the MIA to 
identify a true positive and a true negative sample for both WNV and SLEV.   
 The HAI assay detects total antibody (IgM and IgG) and requires a confirmation 
test to identify a recent infection (IgM), and to distinguish between WNV and SLEV.  
The detection of IgM antibodies may not be equally as effective as the detection of IgG 
antibodies in the HAI.  One advantage of the MIA is that it detects IgM antibodies and is 
able to distinguish between WNV and SLEV.  For example, 11 negative HAI sera tested 
WNV positive in the MAC-ELISA, MIA, and PRNT.  The convalescent phase of these 
sera later seroconverted in the HAI (flavivirus positive) and confirmed in the MAC-
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ELISA, MIA and PRNT.  The MIA was able to detect antibodies to WNV in these 
samples seven to thirty-six days before the HAI (Figure 17).  Two out of these 11 
negative sera never seroconverted in the HAI, despite detection in the MIA (and 
confirmation in the PRNT).  This example demonstrates that the MIA was capable of 
detecting low levels of IgM antibodies in these sera, which could not be detected by the 
HAI.  These results may be due to a limitation of the HAI that requires a highly skilled 
technician to read and interpret the test results, whereas the MIA is very simple to use, 
and interpretation of results are automated.  Therefore, the MIA would serve as an 
excellent screening test because it is very sensitive, specific, detects IgM antibodies, and 
identifies early antibody response, much superior to the current HAI screening technique. 
 MAC-ELISA is used as a confirmation test and distinguishes between WNV and 
SLEV.  The MAC-ELISA and MIA share similar serological concepts and both can 
detect IgM antibodies.  The MIA was more sensitive (97%) and specific (84%) than the 
MAC-ELISA (91% & 82%, respectively) for the detection of IgM antibodies to WNV 
(Figure 13). The specificity of the MIA establishes the ability of this assay to identify a 
true negative result and reduces the amount of false negatives by the high sensitivity.  
McNemar’s Test (p = 0.8238) and Kappa measure of agreement (K= 0.937) statistically 
showed that the MIA is an excellent predictor of the true value.  The PPV (97%) and 
NPV (84%) were also higher in the MIA compared to the MAC-ELISA (96% & 67%, 
respectively) (Figure 14).   
         These results indicate that the MIA reduces the amount of false positives and false 
negatives. For example, 16 sentinel chicken sera that were negative in the MAC-ELISA 
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were WNV positive in the MIA, and confirmed by PRNT.  Two sera were MAC-ELISA 
and HAI negative and were classified as SLEV positive in the MIA.  Only one of the sera 
was confirmed SLEV positive with PRNT and demonstrated the sensitivity and 
specificity of the MIA to correctly classify a serum sample.  The MAC-ELISA and MIA 
had very similar sensitivity, specificity, PPV, and NPV for the detection of IgM 
antibodies to SLEV in sentinel chicken sera (Figure 15 and 16).  Due to the low 
prevalence of SLEV since the introduction of WNV in Florida, the recommended sample 
size of 950 sera was not reached.  Consequently, this smaller sample size may have 
influenced the results of the MIA for the detection of antibodies to SLEV.   
 The sensitivity, specificity, PPV and NPV were determined by comparing the 
results of each assay, HAI, ELISA, MIA, to a true value.  The true value in this study was 
determined by the combination of the MAC-ELISA and PRNT result, following the 
current testing algorithm.  HAI positive sera were assayed in the MAC-ELISA, and if 
negative in MAC-ELISA, these sera were then tested in the PRNT.  The PRNT, like the 
HAI, detects total antibody (primarily IgG neutralizing antibody) in the sera.  If low 
levels of IgM were present in the sera, the PRNT may not be able to detect the presence 
of these antibodies.  Nine sera were WNV positive in the MIA, but negative in the MAC-
ELISA and PRNT negative.  Consequently, these nine sera could not be confirmed 
positive and were classified as false positives (true value negative).  The convalescent 
phase of these sera were not available for testing.    
 
 
 
 
Figure 13 Comparison of Sensitivity and Specificity for Hemagglutination Inhibition Test  
     (HAI), MAC-ELISA (ELISA), and Microsphere-based Immunoassay (MIA)  
     for the detection of antibodies to WNV.     
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Figure 14 Comparison of Positive Predictive Value and Negative Predictive Value for the  
     Hemagglutination Inhibition Test (HAI), MAC-ELISA (ELISA), and  
     Microsphere-based Immunoassay for the detection of antibodies to WNV.   
 
96 97
70
84
95
67
0
20
40
60
80
100
HAI ELISA MIA
Serological Assay 
Pe
rc
en
t (
%
)
PPV
NPV
 
 
 
 
 
 
 
 
 
 
 
71  
 
Figure 15 Comparison of Sensitivity and Specificity Comparison of Positive Predictive  
      for the Hemagglutination Inhibition Test (HAI), MAC-ELISA (ELISA), and  
                 Microsphere-based Immunoassay for the detection of antibodies to SLEV.   
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Figure 16 Comparison of Positive Predictive Value and Negative Predictive Value for the  
     Hemagglutination Inhibition Test (HAI), MAC-ELISA (ELISA), and  
     Microsphere-based Immunoassay for the detection of antibodies to SLEV.   
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Figure 17 Combination of MIA and HAI Results for West Nile Virus in Five Chicken  
     Sera.  Each chicken was tested twice in the MIA and these adjusted MFI results  
     are depicted as bars. HAI antibody titers are also shown for each chicken and  
     represent first time seroconversions (line of the same color for MIA numbers).   
     Sera samples were not tested at every time point.  Once the HAI assay detected  
     antibodies in sera for the first time, additional convalescent sera were not  
     evaluated further. This data illustrates the ability of the MIA to detect low  
     levels of virus specific antibody earlier than the HAI.   
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A Combination of MIA and HAI Results for WNV in Five Sentinel Chickens 
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A recommendation would be to conduct parallel testing with the current testing algorithm 
to identify the true values of the sera and allow for a truly random sample to be tested.  
Parallel testing would also help to determine the appropriate confirmation algorithm 
needed for the MIA.  
 The correlation of prevalence with sensitivity, specificity, PPV, and NPV by 
month for WNV showed similar results in MIA.  The sensitivity and PPV of the MIA and 
MAC-ELISA are more robust to changes in prevalence and the specificity and PPV of the 
HAI is negatively influenced by prevalence.  The data for the NPV and specificity for the 
MAC-ELISA showed extreme values, which may be due to the samples that were HAI 
and PRNT positive, but MAC-ELISA negative (11 sera).  These results indicated that the 
MIA test produced accurate results as the prevalence changed from month to month. 
 The results indicate that the MIA is an excellent alterative to the current 
serological methods.  A total of 18 sentinel chicken sera can be assayed on a 96 well plate 
for the detection of antibodies to WNV using the MAC-ELISA.  A separate plate is 
needed for the SLEV antigen.  The HAI can assay 24 sera on a 96 well plate for SLEV 
antigen only.  The MIA also uses a 96 well format but can test 40 samples for the 
presence of IgM antibodies to WNV and SLEV simultaneously.  A cost analysis was 
evaluated to compare the HAI, MAC-ELISA, and MIA.  The current cost per sample for 
the HAI is $6.00 for the flavivirus group, $12.00 for MAC-ELISA for WNV and SLEV, 
and $50.00/antigen pair (WNV and SLEV) for the PRNT (Personal communication with 
Dr. Lillian Stark, 2005).  It was determined that the cost per sample for the MIA is $9.30 
for the WNV and SLEV antigen pair (Table 14).  This price is very comparable to the  
Table 14 Cost Analysis of the MIA for WNV and SLEV Based on 40 Samples. 
Reagents/Supplies Cost in dollars for 40 samples 
Coupled Bead Sets 32 and 57 216
Goat anti-chicken IgM 2
Porcine Anti-goat IgG-Phycoerythrin 45
Multiscreen BV filter plates 11
Plate sealer 2
PBS w/ 1% BSA 1
Multi-channel pipette tips 16
Nalgene brown bottles/ Reagent reservoirs 3
Hands on time (Labor 25.00$/hr) 75
TOTAL 371
MEAN COST PER SAMPLE 
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9.30
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other serological methods, especially if this MIA could replace one or two of the current 
serological assays.  
 An important consideration in implementing a new test in a diagnostic setting is 
the length of time needed to complete the assay and report results.  Current serological  
assays are complex and require more than a single day to complete.  The estimated 
completion times for the current serological methods are as follows: HAI, 3-5 days,  
MAC-ELISA, 2-3 days, and PRNT, 2-3 weeks.  The MIA can be finished within one day 
and requires approximately 3 hours of hands on time.  The most time consuming part of 
this assay was the reading of the plates by the Luminex instrument, especially when more 
than one plate was used.  A full 96 well plate takes about 30 minutes to read in the 
instrument.  Multiple bead sets will also significantly increase read time and should be 
taken into consideration when developing future multiplex assays. However, several 
plates can be finished within one day; a maximum of four plates per day were analyzed in 
this study.  One plate can be read at a time while the other plates are covered with 
aluminum foil and placed in a drawer at room temperature until the instrument is 
available.  Further research should be conducted to determine the total number of plates, 
with multiple bead sets, the instrument can read in one day and the length of time the 
plates can be placed a room temperature before reading. 
 This study focused on the MIA for the detection of flaviviruses in sentinel chicken 
sera.  The current surveillance system includes screening for alphaviruses. It is therefore 
recommended that a future study be conducted to develop a MIA to detect antibodies to 
alphaviruses in sentinel chicken sera.  Ability of the MIA to multiplex may allow for the 
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development of an MIA that detects antibodies to flaviviruses and alphaviruses 
simultaneously and independently. 
 The sentinel chicken surveillance program is a vital component for the control and 
prevention of arboviruses in the state of Florida.  This surveillance system is particularly 
necessary in the state of Florida where the transmission of arboviruses is influenced by 
environmental factors such as climate, heavy rainfall, and hurricanes.  Accurate and rapid 
testing is critical for an immediate public health response in order to identify high risk 
areas, issue medical alerts/advisories, and implement vector control measures.  The 
implementation of the MIA into the already well established sentinel chicken surveillance 
program will decrease turn-around time and provide a rapid and accurate detection tool 
necessary for a surveillance system.   
 In conclusion, a sentinel chicken surveillance program is important for the 
development and implementation of prevention and control measures to protect the 
population.  The MIA has the potential to rapidly and accurately detect recent WNV and 
SLEV infections (IgM antibodies), where it may eliminate the necessity of multiple 
assays, and would be especially advantageous to diagnostic laboratories.  The MIA was 
found to be more sensitive and specific than the HAI and MAC-ELISA for the detection 
of antibodies to WNV and just as sensitive and specific as the MAC-ELISA for the 
detection of antibodies to SLEV in sentinel chicken sera.  Early detection is very 
important to a surveillance system and allows prevention and control measures to be 
implemented in a timely manner. This study concludes that the MIA may be capable of 
providing earlier detection to protect the population.    
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